Baird Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-17,634	Closed	-$4.82M	–	1753
2024 Q2	$4.82M	Buy	17,634 +1,542	+10%	+$448K	0.01%	676
2024 Q1	$5.57M	Buy	16,092 +3,921	+32%	+$1.29M	0.01%	632
2023 Q4	$3.93M	Sell	12,171 -1,700	-12%	-$533K	0.01%	732
2023 Q3	$4.97M	Buy	13,871 +1,034	+8%	+$399K	0.01%	628
2023 Q2	$4.87M	Buy	12,837 +10,077	+365%	+$4.1M	0.01%	630
2023 Q1	$1.32M	Buy	2,760 +367	+15%	+$172K	﹤0.01%	1018
2022 Q4	$1.01M	Buy	2,393 +88	+4%	+$35.5K	﹤0.01%	1065
2022 Q3	$962K	Buy	2,305 +126	+6%	+$62.8K	﹤0.01%	1063
2022 Q2	$1.08M	Buy	2,179 +184	+9%	+$95.8K	﹤0.01%	1053
2022 Q1	$1.12M	Buy	1,995 +203	+11%	+$122K	﹤0.01%	1098
2021 Q4	$1.35M	Buy	1,792 +293	+20%	+$219K	﹤0.01%	1089
2021 Q3	$1.12M	Buy	1,499 +1,048	+232%	+$785K	﹤0.01%	1161
2021 Q2	$291K	Sell	451 -54	-11%	-$32.9K	﹤0.01%	1583
2021 Q1	$289K	Buy	+505	New	+$299K	﹤0.01%	1534
2019 Q4	–	Sell	-7,099	Closed	-$2.36M	–	1509
2019 Q3	$2.36M	Buy	+7,099	New	+$2.32M	0.01%	726